- Home
- USEA vs MBOT Comparison
USEA vs MBOT Comparison
Compare USEA & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- MBOT
- Stock Information
- Founded
- USEA 2004
- MBOT 2010
- Country
- USEA Greece
- MBOT United States
- Employees
- USEA N/A
- MBOT N/A
- Industry
- USEA Marine Transportation
- MBOT Medical/Dental Instruments
- Sector
- USEA Consumer Discretionary
- MBOT Health Care
- Exchange
- USEA Nasdaq
- MBOT Nasdaq
- Market Cap
- USEA 20.0M
- MBOT 16.7M
- IPO Year
- USEA N/A
- MBOT N/A
- Fundamental
- Price
- USEA $2.10
- MBOT $0.93
- Analyst Decision
- USEA Strong Buy
- MBOT Strong Buy
- Analyst Count
- USEA 1
- MBOT 1
- Target Price
- USEA $6.00
- MBOT $7.00
- AVG Volume (30 Days)
- USEA 40.8K
- MBOT 159.1K
- Earning Date
- USEA 11-26-2024
- MBOT 11-13-2024
- Dividend Yield
- USEA 14.29%
- MBOT N/A
- EPS Growth
- USEA N/A
- MBOT N/A
- EPS
- USEA 0.85
- MBOT N/A
- Revenue
- USEA $46,276,000.00
- MBOT N/A
- Revenue This Year
- USEA $36.03
- MBOT N/A
- Revenue Next Year
- USEA $11.85
- MBOT N/A
- P/E Ratio
- USEA $2.48
- MBOT N/A
- Revenue Growth
- USEA 86.18
- MBOT N/A
- 52 Week Low
- USEA $2.05
- MBOT $0.82
- 52 Week High
- USEA $3.00
- MBOT $2.35
- Technical
- Relative Strength Index (RSI)
- USEA 31.62
- MBOT 43.06
- Support Level
- USEA $2.23
- MBOT $0.93
- Resistance Level
- USEA $2.18
- MBOT $1.05
- Average True Range (ATR)
- USEA 0.10
- MBOT 0.05
- MACD
- USEA -0.01
- MBOT -0.00
- Stochastic Oscillator
- USEA 14.29
- MBOT 16.99
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.